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Objectives To explore the time trend and geographical 
distribution of childhood leukaemia incidence over the 
territory of the Italian region of Sardinia. 
Setting All hospitals departments, diagnostic centres 
and social security agencies in Sardinia were regularly 
screened in 1974–2003 to identify, register and review 
the diagnoses of incident cases of haematological 
malignancies (HM). 
Participants The whole child population aged 0–14 
resident in Sardinia. 
Primary and secondary outcome measures Incidence 
and time trend of childhood HM and childhood acute 
lymphoblastic leukaemia (ALL) over the study period, and 
use of Bayesian methods to plot the probability of areas 
with excess incidence on the regional map. 
Results Overall, 675 HM cases, including 378 ALL cases,
occurred among children aged 0–14 years resident in 
Sardinia in 1974–2003, with an incidence rate of 6.97×10-
5 (95% CI 6.47 to 7.51) and 3.85×10-5 (95% CI 3.48 to 
4.26), respectively. Incidence of HM and ALL showed an 
upward trend along the study period especially among 
females. Three communes out of the 356 existing in 1974,
namely Ittiri, Villa San Pietro and Carbonia, stand out as 
areas with excess incidence of HM and ALL in particular 
and another, Carloforte, for ALL only. 
Conclusions Our results might serve as convincing 
arguments for extending the coverage of routine cancer 
registration over the whole Sardinian population,
while prompting further research on the genetic and 
environmental determinants in the areas at risk. 
INTRODUCTION 
Childhood leukaemia is known to manifest 
itself in time/space clusters, which has led 
to speculations whether chance or specific 
aetiological agents might be responsible.1 
In the past decades, several clusters of child-
hood leukaemia occurred in different areas 
of the island of Sardinia, Italy2 3 (Stazi A, 
personal communication), raising public 
concern about a possible association with 
environmental factors or parental exposures. 
Although, in one instance, it was possible to 
reject a direct connection with parental expo-
sures,4 an analysis of incidence by age groups 
and time windows allowed to hypothesise that 
Strengths and limitations of this study 
► We explored time trends of childhood haemolym-
phatic malignancies in Sardinia, Italy over 30 years 
using a regional registry. 
► Bayesian statistics allowed us to describe the geo-
graphical pattern of childhood haemolymphatic ma-
lignancies in Sardinia. 
► The causes of the observed increasing incidence 
and clustering of childhood acute lymphoblastic leu-
kaemia are still unknown. 
environmental factors might have indeed 
generated the observed time/space concen-
tration of cases.5 What the nature of such 
environmental factors would be, however, was 
never clarified. 
The region of Sardinia is the second largest 
Mediterranean island, and it is well known 
for the genetic peculiarities of its population, 
resulting from millennia of isolation and pres-
sure from malaria.6 While important research 
projects have addressed the genetic bases 
of the concentration of male centenarians 
in specific areas,7 and the high prevalence 
of neurological diseases, such as multiple 
sclerosis, among the Sardinian population,8 
we are not aware of investigations aiming to 
identify the varying prevalence of gene poly-
morphisms implicated in childhood haema-
tological malignancies (HM) in general, and 
acute lymphoblastic leukaemia (ALL) in 
particular, over the island. The geographical 
distribution of the cases can provide clues in 
this regard. 
A cancer registry was active from the 1990s 
only in northern Sardinia, covering approxi-
mately one-third of the regional population. 
Therefore, from the very beginning of the 
‘A. Businco’ Oncology Hospital in 1974 in 
Cagliari, the capital and major urban centre in 
Sardinia, the chief oncohaematologist regis-
tered and updated all cases of oncohaema-
tology malignancies incident in the regional 
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all the clinical, surgical and pathology departments, social 
security agencies and health authorities, as described else-
where.9 The validity and completeness of this database 
were previously assessed by comparison with mortality and 
hospitalisation data.10 We used this database to explore 
time trend and geographical distribution of childhood 
leukaemia over the territory of Sardinia, Italy. 
MATERIAL AND METHODS 
A detailed description of the database of haemolym-
phatic malignancies we used in this study can be found 
elsewhere.9 Briefly, it includes 14744 incident cases of 
any haematological cancer, in both genders, and at any 
age over in the Italian region of Sardinia in 1974–2003. 
For the purposes of this analysis, we selected the 675 
cases occurring among children up to age 14, the cut-off 
for paediatric age in Italy. For each case, we considered 
the commune of residence at the time of the diagnosis. 
Such information was missing for 24/675 cases (3.6%), 
which, therefore, did not contribute to the analysis of the 
spatial distribution of the probability of occurrence of the 
disease. 
The resident population of each commune by gender 
and age groups was available from the 1971, 1981, 1991 
and 2001 population censuses. To estimate the resident 
population in the intercensal years, we extended each 
census data 4years onwards and 5years backwards. The 
standardised annual incidence rate of all HM, and ALL 
among the resident child population was calculated 
along the study period using the person-years of the total 
regional population for each gender, and age group (0–4, 
5–14 years) as the standard. Annual incidence rates were 
plotted by year, and the Pearson’s correlation coefficient 
was calculated based on the equation describing the 
linear regression. 
To explore the geographical distributions of HM and 
ALL, the most common cancer among children under 
the age of 14, we have used a Bayesian approach to char-
acterise the incidence in each commune, the term used 
in some European countries to indicate the smallest local 
administrative unit, that is, town, city or village, which 
has its own council and governs a territory. The map of 
the territorial borders of the 356 individual communes 
existing in 1974 over the region of Sardinia is available 
online (https:\\umap.geonue.com/en/map/confini-e-
dati-statistici-dei-comuni-ditalia_297#8/40.102/8.973).
Another 21 were created along the 30 years of follow-up 
by separation from the original administrative unit, 
which we kept considering as one for consistency with the 
initial map. The objective is to identify those communes 
for which there is a high probability that the incidence 
rate is higher than average. We interpret this to be the 
communes for which the incidence probability exceeds 
some critical value determined from data for the region. 
The Bayesian approach11 combines information about 
the incidence gathered from across the whole regional 
territory with specific data for individual communes. The 


















where P(η|d,I) refers to the posterior probability distri-
bution of the cancer incidence rate η for an individual 
commune, hereafter referred to as incidence probability, 
that is, the probability associated with each value of η, 
after the data d for the commune has been combined with 




 is the prior 
information about the standardised incidence rate, η, of 
childhood cancer given the background information, I 




 is the 
likelihood function, that is, the probability of getting the 
measured data d for the commune if we assume that the 




 does not depend on η; it 
ensures that the integral of the posterior probability over 





a properly defined probability density function. 
The prior summarises what is known about the stan-
dardised incidence rate, η, considering solely the regional 
data. In the definition, the following information is used: 
► The incidence probability is a number in the interval 
between 0 and 1. 
► The condition is rare, implying a low value for the 
incidence probability. 
► It is acceptable to use data from the whole island when 
analysing data at the individual commune level. 
► A few communes might have incidence probabili-
ties higher than the rest of the island for genetic or 
geographical factors. 
This information is summarised with a β distribution, 
where the mean is the same as the mean for the whole 
island, and the mode is half of the mean value. The exact 
shape of the prior probability density function changes 
with the age and gender subgroup being considered. 
The prior for an example can be seen in figure 1; in this 
particular case, the mean is at 5.8 and the mode is at 2.9. 
Incident rates above 25 have an approximate probability 
of 0. 
Whether an individual child succumbs or not to the 
disease in a given year is a binomial process. Therefore, 
the number of cases observed k, in a population of size n 
, measured in child-years, is best described by a binomial 
distribution, which, since k ≪ n, we can approximate with 















where n˜ is the expected number of cases in a popula-
tion of size n. Given the number of cases and the popula-
tion size in each commune, it is possible to calculate the 
probability of the observed number of cases for all values 
of ˜. In figure 1 is the likelihood function for an example 
commune, which is a function of the incidence proba-
bility η. The mode is at 6.9 and there is a wide range of 
possible incidence rates, 0–35, which are consistent with 
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Figure 1 Plot of the prior probability distribution of the 
haematological malignancies in Sardinia, Italy, the likelihood 
function, and the posterior probability of a commune taken 
as an example. There is not a vertical scale to stress the 
relevance of the shape of the curve. The likelihood function 
has been rescaled. The thin vertical line indicates the critical 
value, and it shows that a substantial portion of the posterior 
probability curve lies beyond it. 
The posterior probability combines the prior knowl-
edge with the information that can be obtained from the 
data via the likelihood function, according to Bayes rule, 
as shown in equation 1. Figure 1 shows the result. This 
analysis was repeated for the gender and age subgroups 
within each commune. 
If we carry out the same type of analysis for the whole 
region, the posteriors are almost indistinguishable for any 
reasonable choice of prior. So, we used a uniform prior 
to generate the posterior function. Different priors at 
commune and regional levels are used because different 
information is available at the two levels. At the commune 
level, we can use information that was derived at regional 
level. We then defined the critical value as the value such 
that the probability that the incidence rate for the region 
is less than the critical value is 0.999, that is, ˆ ˜c 
Prob 
(






d˜ = 0.999 
0 
where D is the data for the whole region. The data sets 
d referred to earlier are for the communes and are not 
identical to the equivalent data D for the region. The 
choice of 0.999 is arbitrary, but the subsequent analysis 
is not sensitive to the value chosen. In figure 1, this value 
is marked by the thin vertical line. The critical values, as 
calculated at regional level, are given in table 1. 
Table 1 Critical values ˜c calculated using regional data 
for haemolymphatic cancer among children of age 0–14 in 
Sardinia, Italy in 1974–2003, by age and gender 
Critical value of Critical incidence 
Group ˜ (˜c) rate 
0–4 female 0.0000850 8.50 per 100000 
5–14 female 0.0000735 7.35 per 100000 
0–4 male 0.0001110 11.10 per 100000 
5–14 male 0.0000930 9.30 per 100000 
Figure 2 Map of 1974–2003 childhood haemolymphatic 
cancer incidence in Sardinia, Italy. P values of exceeding the 
threshold incidence rate are presented by commune with 
the following colour scales: white <0.17, pale grey 0.17–0.5, 
medium grey 0.5–0.75, dark grey 0.75–0.95, black >0.95. 
(A) All haemolymphatic cancer; (B) acute lymphoblastic 
leukaemia. 
We can now calculate the probability for the hypothesis 
H1, that the incidence rate in a commune is higher than 












For example in figure 1 the probability of H1 is very 
small, as is true of most of the communes. This shows for 
the commune in the example, the probability that the 
incidence rate exceeds the critical rate is less than 0.01. 
The calculation of the probability of exceeding the 
relevant critical incidence rate for all childhood haemo-
lymphatic malignancies and childhood acute leukaemia 
for each commune was carried out using bespoke python 
code. To allow simpler coding and calculations the crit-
ical rates for each group based on the regional data 
are calculated first, followed by the processing of the 
commune data. The results are plotted in the regional 
map (figure 2) using the following colour scales: white 
<0.17, pale grey 0.17–0.50, medium grey 0.51–0.75, dark 
grey 0.76–0.95, black >0.95. 
Patient and public Involvement 
No patient or public was involved. 
RESULTS 
Table 2 shows that the most prevalent diagnosis was acute 
lymphatic leukaemia (ALL), representing more than 55% 
of the total cases, 58.1% among females and 53.0% among 
males. Non-Hodgkin lymphoma followed (18.9%), with 
a higher prevalence among males (20.6%) in respect to 
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Table 2 Incident cases of haemolymphatic cancer among 
children of age 0–14 in Sardinia, Italy in 1974–2003, by 
histology and gender 
Histology Males N (%) Females N (%) Total N (%) 
Acute lymphatic 
leukaemia 
209 (53.0) 169 (60.2) 378 (56.0) 
Acute myeloid 
leukaemia 
42 (10.7) 29 (10.3) 71 (10.5) 
Hodgkin lymphoma 49 (12.4) 27 (9.6) 76 (11.3) 
Non-Hodgkin 
lymphoma 








7 (1.8) 8 (2.8) 15 (2.2) 
Total 394 (100.0) 281 (100.0) 675 (100.0) 
frequently among male cases (12.4%) than female cases 
(9.3%); acute myeloid leukaemia accounted for about 
10% of cases in either gender; other lymphoproliferative 
and myeloproliferative disorders were rarely represented. 
Over the 30 years of observation, the annual age-
standardised incidence rate of childhood haemolym-
phatic cancer was 6.97×10-5 (95%CI 6.47 to 7.51), 7.93 
(95% CI 7.19 to 8.75) among males and 5.96 (95% CI 
5.30 to 6.69) among females, with a male/ female ratio of 
1.41. The 378 childhood ALL cases corresponded to an 
overall incidence rate of 3.85×10-5 (95%CI 3.48 to 4.26), 
4.14 (95% CI 3.62 to 4.75) among males and 3.55 (95% 
CI 3.05 to 4.12) among females, with a male to female 
ratio of 1:24. 
Graphs in figure 3 show the trend of HM and all over 
the 30-year period, by gender. Incidence of HM increased 
by 0.12×10-5 per year on average along the study period 
(p=0.004). The increasing trend was observed particu-
larly among females (0.18×10-5 per year, p=0.015). ALL 
incidence did not increase in the overall population and 
among males (p=0.868, and p=0.171, respectively), but it 
did show an increase among females aged 5–14 (0.09×10-5 
per year, p=0.039). 
Figure 2 maps the probability that the incidence rate of 
HM and ALL in each commune is above the critical rate, 
overall and by age, and gender. Three stand out with a 
probability around or above 95%; these are Carbonia (23 
cases, p=0.945), Ittiri (11 cases, p=0.980) and Villa San 
Pietro (5 cases, p=0.963). Several other communes have 
a probability ranging 75%–94%, based on three or more 
cases. On the map, these seem scattered over the regional 
territory, with no tendency to cluster in specific areas. 
The same three communes standing out for HM, also 
showed a probability above 95% that the incidence of ALL 
was above the critical rate. Such probability was 0.976 for 
Carbonia (based on 18 cases), 0.983 for Ittiri (based on 9 
cases) and 0.973 for Villa San Pietro (based on 5 cases,). 
For ALL, a probability above 95% was also observed 
for Carloforte (0.952, based on six cases). Another six 
showed a probability between 75% and 94%. Again, these 
were scattered all over the regional territory, and did not 
show a tendency to cluster in specific areas. 
Figure 4 shows the ALL map by age group (0–4 and 
5–14 years) and by gender. We explored the distribution 
of the cases by age groups in the hypothesis that cases 
occurring at age 5–14 would be less likely related to in 
utero events in respect to postnatal exposures. One 
commune only, Ittiri, stands out in both genders and 
both age groups; communes showing a high probability 
of an increase in ALL occurrence were more numerous at 
age 5–14 in respect to age 0–4, and in females in respect 
to males. 
DISCUSSION 
Our results show that the incidence of childhood cancer 
of the haemolymphopoietic system, and particularly 
ALL, increased in the Italian region of Sardinia among 
females; among male children we observed and upward 
time trend of all haemolymphatic malignancies, while 
that of ALL was weaker and not significant. The slope 
of the regression line was apparently steeper for cases 
occurring between age 5 and 14, which would point out 
to a postnatal exposure, or to internal migration effects. 
Apart from chance, we do not have a clear explanation 
for the gender-specific excesses we observed in several 
communes. 
The excess ALL incidence in Carbonia, Ittiri and Villa 
San Pietro had been the object of specific cluster anal-
yses,3–5 or published2 and unpublished (Stazi A. personal 
communication) descriptive reports. In this paper, we 
detected an ALL excess also in Carloforte. As for the 
other communes, with probabilities ranging 75%–94%, 
the chances of a false positive finding appear too large to 
express a conclusion with the same level of confidence. 
All these appear to be far apart from each other. One 
is located in proximity to a large petrochemical plant, 
but benzene emissions in the surroundings have been 
reported to be lower than emissions from urban traffic.12 
Another is located in south western Sardinia, at a distance 
of 12km from a major industrial settlement, which emis-
sions, including mainly lead, cadmium, fluoride, and 
dust were pointed at as plausible causes of the local ALL 
cluster in the 1980s. However, a detailed analyses of the 
cases did not find a relationship with paternal exposures, 
or specific environmental exposures,4 although the pecu-
liar concentration of cases in specific age groups by birth 
cohort suggested that some unidentified environmental 
factors, whether physical, chemical or biological, were 
most likely to have contributed.5 We are not aware of 
other environmental factors that might have generated 
the observed excesses in the other communes. None 
of them is located nearby the military area which had 
been the object of unsubstantiated claims of generating 
hazardous emissions in the surrounding area.10 Uncer-
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 Figure 3 1974–2003 annual incidence rate of total childhood haematological malignancies (cHM) and acute lymphoblastic 
leukaemia (cALL) in Sardinia, Italy, by gender (A, B) and overall (C1, C2). 
a causative role in ALL, apart from infections in the first 
year of life.13 14 
Other possible explanations include polymorphisms 
of genes implicated in the pathways leading to child-
hood leukaemia. Most genetic susceptibility studies have 
focused on immune function, response to infection, one-
carbon metabolism, membrane transport, xenobiotic 
phase I and phase II metabolism of environmental carcin-
ogens, reactive oxygen species deactivation and DNA 
repair enzymes.15 Genome Wide Association Studies of 
B-cell precursor ALL have suggested a polygenic suscepti-
bility to ALL with significant associations with specific loci 
at chromosomes 7, 9, 10, 12, and 14, and more recently at 
chromosomes 2 and 8.16 
However, although Sardinia is well known for the 
genetic peculiarities of its population,6 we are not aware 
of genetic investigations aiming to identify the varying 
prevalence of gene polymorphisms implicated in ALL. 
While this might explain excesses located in isolated 
villages, it would not account for the excess observed in 
Carbonia. This town was ex novo built in 1936–1938 to 
host the coal miner families coming from all over Italy 
to work in the local coal mines. Herd immunity has been 
called as responsible of ALL clusters in the so called 
‘new towns’13; however, around five decades had passed 
between Carbonia foundation and the occurrence of 
the ALL cluster. Also, the population living in the small 
island of Carloforte has different ethnic origin than 
the population of mainland Sardinia, originating from 
Genovese prisoners who moved there from the Tunisian 
site of Tabarka in 1738. It is unclear whether this might 
be related to the excess incidence of ALL observed in 
Carloforte. 
One possible alternative explanation of the clustering of 
ALL cases in specific areas and within specific time frames 
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 Figure 4 Geographical distribution of the 1974–2003 
probability of childhood acute lymphoblastic leukaemia 
incidence above the threshold by commune in Sardinia, Italy. 
(A) 0–4 years (M+F); (B) 5–14 years (M+F); (C) females (age 
0–14); (D) males (age 0–14). 
in detecting the disease, and in referring the sick children 
to the haematology departments. Such ability might have 
increased along the study period, generating a spurious 
increasing trend,9 and might also have spuriously gener-
ated the geographical differences we observed. However, 
we observed an increasing trend mainly in females, while 
we would have expected a spurious increasing trend to 
clearly show up in both genders, unless the diagnostic 
ability differed by gender, which seems unlikely. Post-
diagnosis relocation of the families seems also unlikely to 
have occurred, as the excesses occurred mainly in small 
towns and villages, and not in the major urban areas 
where the hospitals with the specialist oncohaematology 
units are located. 
Concern in interpreting our results might be raised 
because of the wide range in population size between 
communes, from less than 100 to more than 150 000, 
which would be reflected by the childhood population at 
risk. To minimise the number of false positive findings 
related to random variations in the observation of a small 
number of events, we first set at p<0.001 the critical value 
in the prior probability distribution of the standardised 
incidence rate with reference to the prior expectation. 
Then, in each commune, we considered the posterior 
probability of exceeding that critical value. 
An advantage of our study is that the diagnoses were 
all reviewed by the same expert haematologist (GB), 
thus preventing bias due to the varying diagnostic ability 
by time and geographical area, and minimising and 
spreading equally the probability of misdiagnosis over the 
whole region and along the study period. 
Along the period covered by our follow-up study, a 
cancer registry was active only in northern Sardinia, 
covering two local health units and approximately 30% of 
the regional population. A second cancer registry started 
operating in 2006, 3years after the end of recruiting inci-
dent childhood HM cases for the data base we herein 
analysed, covering two local health units in the central-
eastern area of the region and extending the coverage to 
43% of the regional population.17 Therefore, a study such 
as the one we conducted would not have been possible if 
not by collecting and reviewing personally the incident 
cases, with the support of the clinical departments and 
health authorities over the whole region. Possible reasons 
for the delay in extending the coverage also to the rest 
of the region have been discussed10; plans to create a 
regional cancer registry covering 100% of the regional 
population started about 15 years ago, and they might be 
implemented in the near future. 
CONCLUSION 
This is the first report describing time trends over 30 
years and the geographic pattern of haemolymphatic 
malignancies in Sardinia, a special region for studying 
the interaction between gene polymorphisms and envi-
ronmental factors. Our results will hopefully prompt 
further research, and might serve as convincing argu-
ments for extending the coverage of cancer registration 
over the whole Sardinian population, and for distributing 
the necessary paediatric haematology resources to better 
match the local needs. 
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